November 12, 2024

Optellum’s Solutions Now Available on G-Cloud 14

Optellum G Cloud Announcement

OXFORD, UK 12 Nov 2024: Optellum®, a leading innovator in artificial intelligence (AI) and medical imaging for lung cancer, has become a UK government-accredited supplier on the coveted G-Cloud 14 Framework.

About the G-Cloud 14 framework.

G-Cloud 14 is the latest iteration of the UK government’s cloud procurement framework, allowing public sector organizations to easily access cloud-based services with a focus on innovation, security, and affordability.

What does G-Cloud 14 offer?

  • Supplier due diligence and security: The Crown Commercial Service conducts thorough checks on all suppliers. Optellum displayed its commitment to technical excellence and demonstrated regulatory clearances such as its UKCA mark, compliance with cybersecurity and information security standards, ISO quality adherence, and robust clinical data.
  • Ease of procurement: A quick and simple route to market, focusing on Direct Awards to ensure service mobilization to suit the buyer’s requirements.
  • Value for money: Procured services have a 36-month call-off period (with a 12-month extension option).

About Optellum Virtual Nodule Clinic (VNC).

Optellum Virtual Nodule Clinic is an AI-based clinical decision support software supporting the early identification, diagnosis, timely and guideline-compliant patient management and enhanced risk stratification for the lung nodule patients. It is clinically validated to improve patient outcomes vs. current standard of care.

Useful links.

Contact us for more information: info@optellum.com

Recent posts

August 24, 2026 / News & Press, Partnerships
SimonMed Launches World’s First Seamlessly Integrated AI Lung Nodule Risk Assessment Workflow
SimonMed is creating the first fully automated AI-powered lung cancer risk assessment workflow deployed at enterprise scale, combining multiple FDA-cleared AI technologies into a...
Read more
August 13, 2026 / News & Press, Partnerships
Coreline Soft and Optellum announce intent to collaborate to advance AI...
Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
Read more
June 15, 2026 / News & Press, Partnerships
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated...
Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting...
Read more
Optellum is trusted by industry & academic leaders
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
IntuitiveJohnson & JohnsonConcert AIGE HealthcareNHSUniversity of OxfordVanderbilt University Medical CenterAtrium HealthPenn MedicineUConn HealthJupiter Medical CenterGeorgia Cancer Center Augusta University
Certification
Redefining early intervention of lung disease starting with one of the deadliest, lung cancer
Contact us